Avkare Incorporated recalls

Avkare Incorporated has 5 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 12 Sep 2018. The most frequent reason is potency & assay.

Total recalls5since 2018

Last 12 months0reported

Class I00% of total

Ongoing0latest 12 Sep 2018

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 5 100%Class III 0 0%

Why avkare incorporated is recalled

Potency & Assay5100%

Product types

Blood Pressure Medication5100%

By year

20185100%

All avkare incorporated recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
12 Sep 2018Drug	CLASS II	Valsartan and Hydrochlorothiazide 320 mg recalled by Avkare Incorporated	Avkare Incorporated	Potency & Assay	Nationwide
12 Sep 2018Drug	CLASS II	Valsartan and Hydrochlorothiazide 80 mg/12 recalled	Avkare Incorporated	Potency & Assay	Nationwide
12 Sep 2018Drug	CLASS II	Valsartan and Hydrochlorothiazide 160 mg/12 recalled	Avkare Incorporated	Potency & Assay	Nationwide
12 Sep 2018Drug	CLASS II	Valsartan and Hydrochlorothiazide 160 mg recalled by Avkare Incorporated	Avkare Incorporated	Potency & Assay	Nationwide
12 Sep 2018Drug	CLASS II	Valsartan and Hydrochlorothiazide 320 mg/12 recalled	Avkare Incorporated	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.